RXRX
RXRX
NASDAQ · Biotechnology

Recursion Pharmaceuticals-A

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks
$3.15
-0.02 (-0.63%)
As of Mar 26, 8:56 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 8 57%
Hold 6 43%
Sell 0 0%
Price Target
Analyst Price Target +817.5% upside
Low Target $21.05
Average Target $28.90
High Target $39.88
Current Price $3.15
Current
$3.15
Target
$28.90
$21.05 $28.90 avg $39.88
Scenario Analysis
Bear Case
$21.05
568.3%
Low target
Base Case
$28.90
+817.5%
Avg target
Bull Case
$39.88
+1,166.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.18
-56.1% from high
52-Week Low
$2.98
+5.7% from low
50-Day SMA
$4.31
-26.9% vs SMA
200-Day SMA
$4.89
-35.6% vs SMA
RSI (14)
34.7
Neutral
Target vs 52W High
$28.90
+302.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +22.0%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.9%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +163.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.9%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.9%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.2%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%